CEL-SCI Corp (CVM)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $22.51M
Last updated: Nov 17, 2026 at 11:03 AM ET
CEL-SCI Corp (CVM) Competitors
The companies most similar to CEL-SCI are Evaxion Biotech AS (EVAX), NextCure (NXTC) and Celularity (CELU). By market cap, CEL-SCI ranks 8th of the 13 companies on this page; Elicio Therapeutics (ELTX) is the largest at $42.46M.
Peer Comparison
CVM's ROIC of -109.0% is below the peer median of -96.6%, and its revenue growth of -62.7% is below the median of -4.1%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| CEL-SCI (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| Evaxion Biotech AS (EVAX) | $25.27M | N/A | 0.2x | -115.5% | -79.5% | -100.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Celularity Inc (CELU) | $20.45M | N/A | 1.0x | -245.7% | N/A | -5.3% | 0.00% |
| Lite Strategy, Inc. (LITS) | $25.30M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Elicio Therapeutics Inc. (ELTX) | $42.46M | N/A | N/A | 0.0% | -96.6% | 0.0% | 0.00% |
| Cocrystal Pharma Inc (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $25.29M | N/A | 1.5x | 0.0% | -96.6% | -4.1% | 0.00% |
Similar Companies
These are the 12 companies most similar to CEL-SCI, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Evaxion Biotech AS (EVAX) | Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company... | EVAX competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Celularity Inc (CELU) | Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta. | CELU competitors |
| Lite Strategy, Inc. (LITS) | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. | LITS competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Elicio Therapeutics Inc. (ELTX) | Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. | ELTX competitors |
| Cocrystal Pharma Inc (COCP) | Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic... | COCP competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
Frequently Asked Questions About CVM
Who are CEL-SCI's main competitors?
The companies most similar to CEL-SCI include Evaxion Biotech AS (EVAX), NextCure (NXTC), Celularity (CELU), Lite Strategy (LITS) and Estrella Immunopharma (ESLA), listed from the closest match.
Who is CEL-SCI's biggest competitor?
Elicio Therapeutics (ELTX) is the largest of the similar companies at $42.46M; Evaxion Biotech AS (EVAX) is the closest match by business profile, size, sector and industry.
How does CVM stock compare with its competitors?
CVM's net margin is 0.0% against a peer median of 0.0%.
Which of CEL-SCI's competitors pays a higher dividend?
CEL-SCI pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is CEL-SCI bigger than its competitors?
No. CEL-SCI is 8th by market cap among the 13 companies on this page; the largest is Elicio Therapeutics (ELTX) at $42.46M.
CVM pages: Overview, Earnings, Financials, Competitors